partnerships@4dpath.com
Home
About
About Us
Our Teams
Leadership Teams
Scientific Advisers
Our Science
4D Path Solution
Clinical Validation
Publications & Posters
Solutions
News & Events
Investors
Contact Us
Automated prediction of response to neoadjuvant chemotherapy from digitized H&E slides of pretreatment biopsies of germline BRCA carriers with HER2-negative breast cancer (TBCRC 031)